Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
1-Methylnicotinamide (1 trial)
prtx-100 (1 trial)
Hyperlipidemias (Phase 1)
Hyperlipoproteinemias (Phase 1)
Trials (2 total)
Trial APIs (2 total)